News Headlines

New Study Says Weight-Loss Drugs Cause Hair Thinning

Ozempic packaging

A February 2025 study from the University of British Columbia analyzed adverse event reports from patients using semaglutide, the active ingredient in Ozempic and Wegovy. Researchers found a significant association between the medication and hair loss, especially among women. Though not life-threatening, the side effect is distressing for many patients and often underreported. The study suggests that rapid weight loss and changes in nutrient absorption may contribute to telogen effluvium, a condition in which hair prematurely enters the resting phase and sheds. Physicians are advised to monitor hair health in patients prescribed GLP-1 receptor agonists Ozempic pack.